Stock DVAX DYNAVAX TECHNOLOGIES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Dynavax Technologies Corporation

Equities

DVAX

US2681582019

Market Closed - Nasdaq
Other stock markets
 01:30:00 18/05/2024 am IST 		5-day change 1st Jan Change
11.11 USD -1.51% Intraday chart for Dynavax Technologies Corporation +0.91% -20.53%
14/05 Dynavax Technologies Notified by US FDA That Application for Four-Dose Course of Hepatitis B Vaccine Lacks Sufficient Data MT
14/05 Dynavax Application for Hepatitis B Treatment Ruled Insufficient by FDA DJ
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
DYNAVAX TECHNOLOGIES CORPORATION Stock Dynavax Technologies Corporation
 1.48B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 104B
BIONTECH SE Stock BioNTech SE
 22.41B -
ARGENX SE Stock argenx SE
 22.28B -
GENMAB A/S Stock Genmab A/S
 19.07B
  1. Stock Market
  2. Equities
  3. DVAX Stock
  4. Charts Dynavax Technologies Corporation
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW